We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+8.42%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$80B
AUM Growth
+$5.37B
Cap. Flow
-$213M
Cap. Flow %
-0.27%
Top 10 Hldgs %
23.95%
Holding
3,773
New
259
Increased
1,520
Reduced
1,671
Closed
192

Sector Composition

Rank Sector Weight
1 Technology 14.33%
2 Healthcare 8.9%
3 Financials 7.71%
4 Consumer Discretionary 6.92%
5 Industrials 6.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STIP icon
401
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
$29.9M 0.04%
286,866
+42,834
+18% +$4.43M
BP icon
402
BP
BP
$111B
$29.8M 0.04%
1,705,013
-1,589,539
-48% -$34.4M
NDAQ icon
403
Nasdaq
NDAQ
$53.3B
$29.5M 0.04%
721,350
+28,356
+4% +$1.21M
ELV icon
404
Elevance Health
ELV
$84.6B
$29.5M 0.04%
109,764
-1,470
-1% -$396K
CASY icon
405
Casey's General Stores
CASY
$30.9B
$29.4M 0.04%
165,565
+8,436
+5% +$1.43M
CDNS icon
406
Cadence Design Systems
CDNS
$90B
$29.4M 0.04%
275,749
-21,041
-7% -$2.21M
AWK icon
407
American Water Works
AWK
$26.9B
$29.3M 0.04%
202,476
-5,104
-2% -$723K
MSCI icon
408
MSCI
MSCI
$40.9B
$29.3M 0.04%
82,059
+253
+0.3% +$91.8K
AZO icon
409
AutoZone
AZO
$49.8B
$29.2M 0.04%
24,824
+1,054
+4% +$1.25M
ATR icon
410
AptarGroup
ATR
$8.58B
$29.2M 0.04%
258,207
+20,060
+8% +$2.35M
ALXN
411
DELISTED
Alexion Pharmaceuticals
ALXN
$29.2M 0.04%
254,980
+12,085
+5% +$1.3M
ITOT icon
412
iShares Core S&P Total US Stock Market ETF
ITOT
$97.5B
$29.2M 0.04%
386,280
+16,570
+4% +$1.24M
JCI icon
413
Johnson Controls International
JCI
$93.3B
$29.2M 0.04%
713,692
-37,360
-5% -$1.46M
LKQ icon
414
LKQ Corp
LKQ
$6.27B
$29.1M 0.04%
1,050,959
+163,950
+18% +$4.83M
IUSB icon
415
iShares Core Universal USD Bond ETF
IUSB
$43.2B
$28.9M 0.04%
531,969
+22,984
+5% +$1.26M
IBDM
416
DELISTED
iShares iBonds Dec 2021 Term Corporate ETF
IBDM
$28.8M 0.04%
1,151,262
-24,414
-2% -$612K
AIG icon
417
American International
AIG
$40.6B
$28.4M 0.04%
1,031,494
+19,739
+2% +$588K
TWLO icon
418
Twilio
TWLO
$39.4B
$28.3M 0.04%
114,519
-8,754
-7% -$2.16M
COR icon
419
Cencora
COR
$63B
$28.1M 0.04%
290,020
-22,877
-7% -$2.27M
WDAY icon
420
Workday
WDAY
$44.7B
$28M 0.04%
130,272
+4,604
+4% +$911K
FLOT icon
421
iShares Floating Rate Bond ETF
FLOT
$10.5B
$28M 0.04%
552,220
+26,575
+5% +$1.35M
CMG icon
422
Chipotle Mexican Grill
CMG
$40.7B
$28M 0.04%
1,125,700
+2,000
+0.2% +$48.2K
HAL icon
423
Halliburton
HAL
$28.3B
$27.8M 0.03%
2,309,589
-179,171
-7% -$2.59M
ULTA icon
424
Ulta Beauty
ULTA
$23.3B
$27.8M 0.03%
124,195
+18,339
+17% +$3.95M
XIFR
425
XPLR Infrastructure LP
XIFR
$1.09B
$27.7M 0.03%
461,910
-73,735
-14% -$4.36M

Similar funds

Raymond James & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Raymond James & Associates held 3,773 positions worth $80B, up 7.2% from $74.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2020 filing shows 259 new, 1,520 increased, 1,671 reduced and 192 closed positions. Its largest new stake was Rocket Companies: 405,835 shares worth $8.09M. The largest sale was Apple, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2020 buy was Rocket Companies: 405,835 shares worth $8.09M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2020, an estimated $140M increase.
  • Raymond James & Associates's biggest Q3 2020 reduction was Apple, cutting an estimated $134M.
  • Raymond James & Associates fully exited Invesco Russell 1000 Dynamic Multifactor ETF in Q3 2020, selling an estimated $15.9M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $80B portfolio in Q3 2020.
  • Raymond James & Associates opened 259 new positions and closed 192 in Q3 2020.
  • Raymond James & Associates's portfolio value rose 7.2% quarter-over-quarter to $80B.

Based on Raymond James & Associates's 13F filing for Q3 2020, filed 4 Nov 2020.